Financial Performance

Kewaunee Scientific Q1 Sales Fall 6.7% as Backlog Climbs to $169 Million

Kewaunee Scientific Q1 Sales Fall 6.7% as Backlog Climbs to $169 Million

Statesville, N.C. – – September 16, 2026 -- Kewaunee Scientific Corporation (NASDAQ: KEQU) reported first-quarter fiscal 2027 sales of $66.3 million, down 6.7% from $71.1 million a year earlier, even as order backlog rose to $169.0 million from $165.9 million at the end of April.

Net earnings drop to $1.7 million on lower manufacturing volumes

Pre-tax earnings fell 34.7% to $2.56 million from $3.92 million in the prior-year quarter, while net earnings declined to $1.706 million from $3.093 million. Diluted earnings per share came in at $0.58, down from $1.04. EBITDA for the quarter totaled $4.525 million versus $6.32 million a year ago. Backlog, while up sequentially, remains well below the $205.0 million recorded on September 16, 2026.

Research Solutions Posts Record $2.8M Net Income, B2B ARR Up 14%

Research Solutions Posts Record $2.8M Net Income, B2B ARR Up 14%

Henderson – September 16, 2026 -- Research Solutions, Inc. (NASDAQ: RSSS) reported fiscal year 2026 net income of $2.8 million, more than double the $1.3 million posted in fiscal 2025, as its shift toward higher-margin Platform subscriptions offset a decline in transaction volume.

B2B annual recurring revenue climbs 14.1% to $16.2 million

For the fiscal year ended September 16, 2026, total ARR reached $22.5 million, up 7.8% year-over-year, comprising $16.2 million of B2B recurring revenue and $6.3 million from B2C. The B2B segment added 105 net new platform deployments during the year, while AI-related ARR contributed $0.8 million.